---
title: "Bone Flap Osteomyelitis Following Craniectomy : Retrospective Evaluation of Clinical Presentation, Microbiological Diagnosis and Management"
nct_id: NCT05367713
overall_status: UNKNOWN
sponsor: Hospices Civils de Lyon
study_type: OBSERVATIONAL
primary_condition: Osteitis
countries: France
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05367713.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05367713"
ct_last_update_post_date: 2022-05-10
last_seen_at: "2026-05-12T06:54:44.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Bone Flap Osteomyelitis Following Craniectomy : Retrospective Evaluation of Clinical Presentation, Microbiological Diagnosis and Management

**NCT ID:** [NCT05367713](https://clinicaltrials.gov/study/NCT05367713)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 160
- **Lead Sponsor:** Hospices Civils de Lyon
- **Conditions:** Osteitis, Cranial Flap
- **Start Date:** 2022-04-01
- **Completion Date:** 2022-06-01
- **CT.gov Last Update:** 2022-05-10

## Brief Summary

Osteitis of the cranial flap after craniectomy is an unknown complex osteoarticular infection and there are few data concerning its epidemiology, its risk factors, and its management.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Patients with cranial flap osteitis after craniectomy
* Patients who did not object to participating in the study
* Adult patients

Exclusion Criteria:

* NA
```

## Arms

- **patients having had an osteitis of the cranial flap after craniectomy**

## Interventions

- **patients having had an osteitis of the cranial flap after craniectomy** (OTHER) — description of management and failure of cranial flap after craniectomy

## Primary Outcomes

- **rate of cranial flap osteitis after craniectomy** _(time frame: between 2010 and 2021)_ — proportion of patients

## Secondary Outcomes

- **rate of failure in management of cranial flap osteitis after craniectomy** _(time frame: between 2010 and 2021)_

## Locations (1)

- Hospices Civils de Lyon, Lyon, France — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.hospices civils de lyon|lyon||france` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05367713.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05367713*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*
